Press Releases

WILMINGTON, DE - With our nation's economy struggling and its people more vigilent to terrorist attacks, many are hoping that biotechnology could be a key to our physical and economic security. One the leading bio-tech research areas is Delaware's Biotechnology Park. The leaders of 60 bio-tech companies will meet with Senator Tom Carper this Wednesday morning to talk about their work and some of the newest technologies being developed to meet the new challenges facing our nation. "Delaware is at the forefront in developing a wide range of innovative biotechnology," said Carper. "From agriculture to medicines to bio-defense, Delaware firms are actively engaged in inventing and marketing products that will lead to a healthier, safer, more productive future. Government has played an essential role in this process and could play an even bigger role in the future. We need to continue to work together at the national and the state level to ensure that our biotech businesses are getting the support they need to stay on top." As many as 60 Delaware businesses will attend the morning meeting. Expected attendees include executives from AstraZeneca, Dupont, Agilent, Strategic Diagnostics, Bristol- Myers Squibb, Analytical Biological Services, DNA Bridges, PharmaLeads, Next Century and Quantum Leap. WHO: Senator Tom Carper and leading Delaware businesses WHAT: Delaware Biotech Breakfast WHEN: Wednesday, January 16, 2002 8-9 a.m. WHERE: DE Biotech Institute 15 Innovation Way Newark